STOCK TITAN

[Form 4] Aehr Test Systems Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing – Aehr Test Systems (AEHR) submitted 07/03/2025 discloses insider transactions by Vernon Rogers, Executive Vice President of Sales & Marketing.

  • 13,351 common shares (Transaction Code A) were acquired on 07/02/2025 through restricted stock unit (RSU) vesting at $0 cost. Footnote 1 states 1/16 of the award vests every three months.
  • An additional 1,614 common shares (Code A) vested on the same date at $0 cost; 25% of this award vested immediately, with the remainder vesting quarterly over three years (Footnote 2).
  • 218 shares (Code F) were withheld at $15.13 per share to satisfy tax-withholding obligations (Footnote 3); this is not an open-market sale.
  • After all transactions, Mr. Rogers directly owns 70,390 AEHR shares, which include unvested RSUs (Footnote 4). The filing notes he previously received 6,486 shares upon termination of the company’s ESOP on 04/25/2025.

No derivative securities were reported. The filing reflects routine equity compensation vesting rather than discretionary market purchases or sales.

Dichiarazione Modulo 4 – Aehr Test Systems (AEHR) presentata il 03/07/2025, che rivela operazioni interne da parte di Vernon Rogers, Vicepresidente Esecutivo delle Vendite e Marketing.

  • 13.351 azioni ordinarie (Codice Transazione A) sono state acquisite il 02/07/2025 tramite maturazione di unità azionarie vincolate (RSU) a costo zero. La nota 1 specifica che 1/16 del premio matura ogni tre mesi.
  • Ulteriori 1.614 azioni ordinarie (Codice A) sono maturate nella stessa data a costo zero; il 25% di questo premio è maturato immediatamente, mentre il resto matura trimestralmente in tre anni (Nota 2).
  • 218 azioni (Codice F) sono state trattenute a 15,13 $ per azione per coprire obblighi fiscali (Nota 3); questa non è una vendita sul mercato aperto.
  • Dopo tutte le operazioni, il Sig. Rogers possiede direttamente 70.390 azioni AEHR, comprese RSU non ancora maturate (Nota 4). La dichiarazione indica che in precedenza ha ricevuto 6.486 azioni alla chiusura del piano ESOP aziendale il 25/04/2025.

Non sono stati segnalati titoli derivati. La dichiarazione riflette la maturazione ordinaria di compensi azionari e non acquisti o vendite discrezionali sul mercato.

Declaración del Formulario 4 – Aehr Test Systems (AEHR) presentada el 03/07/2025, que revela transacciones internas por parte de Vernon Rogers, Vicepresidente Ejecutivo de Ventas y Marketing.

  • 13,351 acciones ordinarias (Código de Transacción A) fueron adquiridas el 02/07/2025 mediante la consolidación de unidades restringidas de acciones (RSU) a costo cero. La nota 1 indica que 1/16 del premio se consolida cada tres meses.
  • Un adicional de 1,614 acciones ordinarias (Código A) se consolidaron en la misma fecha a costo cero; el 25% de este premio se consolida inmediatamente, y el resto trimestralmente durante tres años (Nota 2).
  • 218 acciones (Código F) fueron retenidas a $15.13 por acción para cubrir obligaciones fiscales (Nota 3); esto no es una venta en el mercado abierto.
  • Tras todas las transacciones, el Sr. Rogers posee directamente 70,390 acciones AEHR, incluyendo RSU no consolidadas (Nota 4). La declaración señala que previamente recibió 6,486 acciones tras la terminación del ESOP de la empresa el 25/04/2025.

No se reportaron valores derivados. La declaración refleja la consolidación rutinaria de compensación en acciones en lugar de compras o ventas discrecionales en el mercado.

폼 4 제출 – Aehr Test Systems (AEHR) 2025년 7월 3일 제출되었으며, 영업 및 마케팅 부사장 Vernon Rogers의 내부자 거래를 공개합니다.

  • 13,351 보통주 (거래 코드 A)가 2025년 7월 2일 제한 주식 단위(RSU) 베스팅을 통해 비용 없이 취득되었습니다. 각주 1에 따르면 상금의 1/16이 3개월마다 베스팅됩니다.
  • 추가로 1,614 보통주 (코드 A)가 같은 날짜에 비용 없이 베스팅되었으며; 이 상금의 25%는 즉시 베스팅되고 나머지는 3년에 걸쳐 분기별로 베스팅됩니다(각주 2).
  • 218주 (코드 F)가 세금 원천징수 의무를 충족하기 위해 주당 15.13달러에 원천징수되었습니다(각주 3); 이는 공개 시장 판매가 아닙니다.
  • 모든 거래 후, Rogers 씨는 미베스팅 RSU를 포함하여 70,390 AEHR 주식을 직접 보유하고 있습니다(각주 4). 제출서류에는 그가 2025년 4월 25일 회사 ESOP 종료 시 6,486주를 받은 사실도 기록되어 있습니다.

파생 증권은 보고되지 않았습니다. 제출서류는 임의의 시장 매매가 아닌 정기적인 주식 보상 베스팅을 반영합니다.

Dépôt du formulaire 4 – Aehr Test Systems (AEHR) soumis le 03/07/2025, révélant des transactions d’initiés par Vernon Rogers, Vice-Président Exécutif des Ventes et du Marketing.

  • 13 351 actions ordinaires (Code de transaction A) ont été acquises le 02/07/2025 via l’acquisition d’unités d’actions restreintes (RSU) à coût nul. La note 1 indique qu’1/16 de la récompense est acquise tous les trois mois.
  • Un complément de 1 614 actions ordinaires (Code A) a été acquis à la même date à coût nul ; 25 % de cette récompense a été acquis immédiatement, le reste trimestriellement sur trois ans (Note 2).
  • 218 actions (Code F) ont été retenues à 15,13 $ par action pour satisfaire aux obligations fiscales (Note 3) ; il ne s’agit pas d’une vente sur le marché ouvert.
  • Après toutes les transactions, M. Rogers possède directement 70 390 actions AEHR, y compris des RSU non acquises (Note 4). Le dépôt indique qu’il avait précédemment reçu 6 486 actions lors de la clôture du plan ESOP de l’entreprise le 25/04/2025.

Aucun titre dérivé n’a été déclaré. Le dépôt reflète une acquisition régulière de rémunération en actions plutôt que des achats ou ventes discrétionnaires sur le marché.

Formular 4 Einreichung – Aehr Test Systems (AEHR) eingereicht am 03.07.2025, offenbart Insider-Transaktionen von Vernon Rogers, Executive Vice President Sales & Marketing.

  • 13.351 Stammaktien (Transaktionscode A) wurden am 02.07.2025 durch Restricted Stock Unit (RSU) Vesting zu 0 $ Kosten erworben. Fußnote 1 besagt, dass 1/16 der Zuteilung alle drei Monate vestet.
  • Zusätzlich wurden 1.614 Stammaktien (Code A) am selben Datum zu 0 $ Kosten vestet; 25 % dieser Zuteilung vesteten sofort, der Rest vierteljährlich über drei Jahre (Fußnote 2).
  • 218 Aktien (Code F) wurden zu 15,13 $ je Aktie einbehalten, um Steuerabzugsverpflichtungen zu erfüllen (Fußnote 3); dies ist kein Verkauf am offenen Markt.
  • Nach allen Transaktionen besitzt Herr Rogers direkt 70.390 AEHR-Aktien, einschließlich nicht vesteter RSUs (Fußnote 4). Die Einreichung vermerkt, dass er zuvor 6.486 Aktien bei Beendigung des ESOP am 25.04.2025 erhalten hat.

Es wurden keine derivativen Wertpapiere gemeldet. Die Einreichung spiegelt routinemäßiges Vesting von Aktienvergütungen wider und keine diskretionären Markttransaktionen.

Positive
  • Executive increased direct holdings by 14,965 shares, bringing total ownership to 70,390 shares.
  • No discretionary share sales; only minimal shares withheld for taxes, suggesting continued alignment with shareholders.
Negative
  • Shares were acquired through zero-cost RSU vesting, offering limited insight into executive conviction at current market prices.
  • Minor share withholding at $15.13 slightly increases free float, though the effect is negligible.

Insights

TL;DR: Routine RSU vesting—neutral impact; insider retains all vested shares, signaling no negative sentiment.

The Form 4 shows Mr. Rogers added 14,965 shares via scheduled RSU vesting, raising his direct stake to 70,390 shares. The only disposition—218 shares—was a tax-withholding transaction, required under equity-compensation rules. Because the acquisitions were compensation-driven at zero cost, they do not represent an opportunistic market buy. Nonetheless, the absence of discretionary selling and the decision to hold the net shares can be read as a modest confidence indicator. From a valuation or liquidity standpoint, the change is immaterial to AEHR’s float and earnings profile, so I classify the news as neutral with limited market impact.

Dichiarazione Modulo 4 – Aehr Test Systems (AEHR) presentata il 03/07/2025, che rivela operazioni interne da parte di Vernon Rogers, Vicepresidente Esecutivo delle Vendite e Marketing.

  • 13.351 azioni ordinarie (Codice Transazione A) sono state acquisite il 02/07/2025 tramite maturazione di unità azionarie vincolate (RSU) a costo zero. La nota 1 specifica che 1/16 del premio matura ogni tre mesi.
  • Ulteriori 1.614 azioni ordinarie (Codice A) sono maturate nella stessa data a costo zero; il 25% di questo premio è maturato immediatamente, mentre il resto matura trimestralmente in tre anni (Nota 2).
  • 218 azioni (Codice F) sono state trattenute a 15,13 $ per azione per coprire obblighi fiscali (Nota 3); questa non è una vendita sul mercato aperto.
  • Dopo tutte le operazioni, il Sig. Rogers possiede direttamente 70.390 azioni AEHR, comprese RSU non ancora maturate (Nota 4). La dichiarazione indica che in precedenza ha ricevuto 6.486 azioni alla chiusura del piano ESOP aziendale il 25/04/2025.

Non sono stati segnalati titoli derivati. La dichiarazione riflette la maturazione ordinaria di compensi azionari e non acquisti o vendite discrezionali sul mercato.

Declaración del Formulario 4 – Aehr Test Systems (AEHR) presentada el 03/07/2025, que revela transacciones internas por parte de Vernon Rogers, Vicepresidente Ejecutivo de Ventas y Marketing.

  • 13,351 acciones ordinarias (Código de Transacción A) fueron adquiridas el 02/07/2025 mediante la consolidación de unidades restringidas de acciones (RSU) a costo cero. La nota 1 indica que 1/16 del premio se consolida cada tres meses.
  • Un adicional de 1,614 acciones ordinarias (Código A) se consolidaron en la misma fecha a costo cero; el 25% de este premio se consolida inmediatamente, y el resto trimestralmente durante tres años (Nota 2).
  • 218 acciones (Código F) fueron retenidas a $15.13 por acción para cubrir obligaciones fiscales (Nota 3); esto no es una venta en el mercado abierto.
  • Tras todas las transacciones, el Sr. Rogers posee directamente 70,390 acciones AEHR, incluyendo RSU no consolidadas (Nota 4). La declaración señala que previamente recibió 6,486 acciones tras la terminación del ESOP de la empresa el 25/04/2025.

No se reportaron valores derivados. La declaración refleja la consolidación rutinaria de compensación en acciones en lugar de compras o ventas discrecionales en el mercado.

폼 4 제출 – Aehr Test Systems (AEHR) 2025년 7월 3일 제출되었으며, 영업 및 마케팅 부사장 Vernon Rogers의 내부자 거래를 공개합니다.

  • 13,351 보통주 (거래 코드 A)가 2025년 7월 2일 제한 주식 단위(RSU) 베스팅을 통해 비용 없이 취득되었습니다. 각주 1에 따르면 상금의 1/16이 3개월마다 베스팅됩니다.
  • 추가로 1,614 보통주 (코드 A)가 같은 날짜에 비용 없이 베스팅되었으며; 이 상금의 25%는 즉시 베스팅되고 나머지는 3년에 걸쳐 분기별로 베스팅됩니다(각주 2).
  • 218주 (코드 F)가 세금 원천징수 의무를 충족하기 위해 주당 15.13달러에 원천징수되었습니다(각주 3); 이는 공개 시장 판매가 아닙니다.
  • 모든 거래 후, Rogers 씨는 미베스팅 RSU를 포함하여 70,390 AEHR 주식을 직접 보유하고 있습니다(각주 4). 제출서류에는 그가 2025년 4월 25일 회사 ESOP 종료 시 6,486주를 받은 사실도 기록되어 있습니다.

파생 증권은 보고되지 않았습니다. 제출서류는 임의의 시장 매매가 아닌 정기적인 주식 보상 베스팅을 반영합니다.

Dépôt du formulaire 4 – Aehr Test Systems (AEHR) soumis le 03/07/2025, révélant des transactions d’initiés par Vernon Rogers, Vice-Président Exécutif des Ventes et du Marketing.

  • 13 351 actions ordinaires (Code de transaction A) ont été acquises le 02/07/2025 via l’acquisition d’unités d’actions restreintes (RSU) à coût nul. La note 1 indique qu’1/16 de la récompense est acquise tous les trois mois.
  • Un complément de 1 614 actions ordinaires (Code A) a été acquis à la même date à coût nul ; 25 % de cette récompense a été acquis immédiatement, le reste trimestriellement sur trois ans (Note 2).
  • 218 actions (Code F) ont été retenues à 15,13 $ par action pour satisfaire aux obligations fiscales (Note 3) ; il ne s’agit pas d’une vente sur le marché ouvert.
  • Après toutes les transactions, M. Rogers possède directement 70 390 actions AEHR, y compris des RSU non acquises (Note 4). Le dépôt indique qu’il avait précédemment reçu 6 486 actions lors de la clôture du plan ESOP de l’entreprise le 25/04/2025.

Aucun titre dérivé n’a été déclaré. Le dépôt reflète une acquisition régulière de rémunération en actions plutôt que des achats ou ventes discrétionnaires sur le marché.

Formular 4 Einreichung – Aehr Test Systems (AEHR) eingereicht am 03.07.2025, offenbart Insider-Transaktionen von Vernon Rogers, Executive Vice President Sales & Marketing.

  • 13.351 Stammaktien (Transaktionscode A) wurden am 02.07.2025 durch Restricted Stock Unit (RSU) Vesting zu 0 $ Kosten erworben. Fußnote 1 besagt, dass 1/16 der Zuteilung alle drei Monate vestet.
  • Zusätzlich wurden 1.614 Stammaktien (Code A) am selben Datum zu 0 $ Kosten vestet; 25 % dieser Zuteilung vesteten sofort, der Rest vierteljährlich über drei Jahre (Fußnote 2).
  • 218 Aktien (Code F) wurden zu 15,13 $ je Aktie einbehalten, um Steuerabzugsverpflichtungen zu erfüllen (Fußnote 3); dies ist kein Verkauf am offenen Markt.
  • Nach allen Transaktionen besitzt Herr Rogers direkt 70.390 AEHR-Aktien, einschließlich nicht vesteter RSUs (Fußnote 4). Die Einreichung vermerkt, dass er zuvor 6.486 Aktien bei Beendigung des ESOP am 25.04.2025 erhalten hat.

Es wurden keine derivativen Wertpapiere gemeldet. Die Einreichung spiegelt routinemäßiges Vesting von Aktienvergütungen wider und keine diskretionären Markttransaktionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROGERS VERNON

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec VP of Sales & Mktg.
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 13,351(1) A $0 68,994 D
Common Stock 07/02/2025 A 1,614(2) A $0 70,608 D
Common Stock 07/02/2025 F 218(3) D $15.13 70,390(4) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates.
2. 25% of shares subject to the restricted stock unit awards shall vest immediately and the remaining 75% of shares will vest quarterly over the remaining 3 years.
3. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
4. The amount reported includes shares subject to unvested restricted stock units. Mr. Vernon Rogers received 6,486 shares due to the termination of the Company's Employee Stock Ownership Plan on 04/25/2025. The closing price was $8.76 per share.
Remarks:
/s/Chris Siu, Attorney-in-Fact 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AEHR shares did EVP Vernon Rogers acquire in the latest Form 4?

14,965 common shares were added through two RSU vesting events on 07/02/2025.

What is Vernon Rogers’ total AEHR share ownership after the transactions?

He directly owns 70,390 shares, including unvested RSUs.

Were any AEHR shares sold by the insider?

No open-market sales occurred; 218 shares were withheld solely to cover taxes.

At what price were shares withheld for taxes?

Shares were withheld at $15.13 per share (Transaction Code F).

Do the transactions indicate a change in insider sentiment toward AEHR?

Because the acquisitions were scheduled RSU vestings at no cost, they are viewed as routine and neutral rather than a directional signal.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

379.59M
28.11M
5.06%
72.02%
24.14%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT